IDEX Biometrics ASA - Key Information Relating to Possible Subsequent Offering/repair Issue
IDEX Biometrics ASA - Key Information Relating to Possible Subsequent Offering/repair Issue
The Subsequent Offering will be carried out as set out in an offering prospectus (which must be approved by the Norwegian Financial Supervisory Authority) to be published prior to commencement of the subscription period. Oslo, 15 May 2024
2024年5月15日，奧斯陸。
Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 15 May 2024 regarding a private placement of shares in the Company raising approximately NOK 55 million at a subscription price of NOK 1.65 per share (the "Private Placement") and a possible subsequent offering, raising up to NOK 13,200,000, at the same subscription price as in the private placement (the "Subsequent Offering"), subject to approval by an Extraordinary General Meeting to be held on or about 12 June 2024.
參考IDEX生物識別公司（“IDEX”或“公司”）於2024年5月15日發佈的一則交易所公告，該公司完成了一項定向增發，募集了約5500萬挪威克朗的股份，認購價格爲每股1.65挪威克朗（“定向增發”），以及可能的後續發行，最多募集1,320萬挪威克朗，認購價格與定向增發相同（“後續發行”）。該後續發行需經特別股東大會批准，該會議將於2024年6月12日左右舉行。
Date on which the terms and conditions of the repair issue were announced: 15 May 2024;
Last day including right: 15 May 2024;
Ex-date: 16 May 2024;
Record date: 21 May 2024;
Date of approval: Expected to be on or about 12 June 2024 by resolution of an Extraordinary General Meeting (to be called);
Maximum number of new shares: 8,000,000; and
Subscription price: NOK 1.65.
修復問題的條款和條件公佈的日期： 2024年5月15日;
包含權利的最後一天：2024年5月15日;
除淨日：2024年5月16日;
股權登記日：2024年5月21日;
批准日期：預計於2024年6月12日左右通過特別股東大會（召開）通過;
新增股票的最大數量：8,000,000;及
認購價格：1.65挪威克朗。
The Subsequent Offering will be carried out as set out in an offering prospectus (which must be approved by the Norwegian Financial Supervisory Authority) to be published prior to commencement of the subscription period.
後續發行將以發行說明書的方式進行（該說明書必須得到挪威金融監管機構的批准），並將在認購期開始前發佈。
This information is published in accordance with the requirements of the Continuing Obligations.
此信息依據持續義務的要求發佈。
譯文內容由第三人軟體翻譯。
